ED
EW icon

Exane Derivatives’s Edwards Lifesciences EW Stock Holding History

Exane Derivatives’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-183
Closed -$21.5K – 848
2022
Q1 		$21.5K Sell
183
-370
-67% -$41.5K 0.01% 657
2021
Q4 		$71.6K Sell
553
-686
-55% -$80K 0.02% 468
2021
Q3 		$140K Sell
1,239
-65
-5% -$7.42K 0.03% 475
2021
Q2 		$139K Sell
1,304
-495
-28% -$46.7K 0.03% 497
2021
Q1 		$150K Sell
1,799
-883
-33% -$74.7K 0.04% 337
2020
Q4 		$245K Sell
2,682
-2,496
-48% -$207K 0.07% 279
2020
Q3 		$413K Sell
5,178
-210
-4% -$16.4K 0.12% 154
2020
Q2 		$372K Buy
5,388
+5,382
+89,700% +$382K 0.1% 177
2020
Q1 		$377 Hold
6
– – ﹤0.01% 625
2019
Q4 		$473 Hold
6
– – ﹤0.01% 614
2019
Q3 		$440 Hold
6
– – ﹤0.01% 594
2019
Q2 		$369 Sell
6
-84
-93% -$5.08K ﹤0.01% 615
2019
Q1 		$5.74K Hold
90
– – ﹤0.01% 412
2018
Q4 		$4.59K Hold
90
– – ﹤0.01% 498
2018
Q3 		$5.23K Buy
90
+9
+11% +$440 ﹤0.01% 462
2018
Q2 		$3.93K Buy
81
+15
+23% +$700 ﹤0.01% 478
2018
Q1 		$3.01K Sell
66
-3,573
-98% -$155K ﹤0.01% 438
2017
Q4 		$137K Buy
3,639
+2,883
+381% +$106K 0.02% 263
2017
Q3 		$27.5K Sell
756
-171
-18% -$6.52K 0.01% 343
2017
Q2 		$36.5K Sell
927
-42
-4% -$1.53K 0.01% 337
2017
Q1 		$30.4K Buy
+969
New +$30.3K 0.01% 298
2016
Q4 		– Sell
-2,202
Closed -$88.5K – 663
2016
Q3 		$88.5K Sell
2,202
-1,338
-38% -$50.4K 0.01% 253
2016
Q2 		$118K Sell
3,540
-72
-2% -$2.46K 0.02% 231
2016
Q1 		$106K Buy
+3,612
New +$99.7K 0.01% 235
2015
Q4 		– Sell
-2,070
Closed -$49K – 540
2015
Q3 		$49K Buy
+2,070
New +$50K 0.01% 268

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's EW Position: Q2 2022 in Review

Exane Derivatives sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 183 shares — an estimated $21.5K sold.

Exane Derivatives first reported a position in EW in Q3 2015 and held it in 25 quarters. The position peaked at $413K in Q3 2020. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Exane Derivatives reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 183 Edwards Lifesciences shares in Q2 2022, an estimated $21.5K.
  • Exane Derivatives first reported a position in Edwards Lifesciences in Q3 2015 and held it in 25 quarters.
  • Exane Derivatives's Edwards Lifesciences position peaked at $413K in Q3 2020.
  • 1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.